[HTML][HTML] Therapeutic agents for oxaliplatin-induced peripheral neuropathy; experimental and clinical evidence
T Kawashiri, K Mine, D Kobayashi, M Inoue… - International journal of …, 2021 - mdpi.com
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
Therapeutic agents for oxaliplatin-induced peripheral neuropathy; experimental and clinical evidence
T Kawashiri, K Mine, D Kobayashi… - International …, 2021 - kyushu-u.elsevierpure.com
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
[PDF][PDF] Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
T Kawashiri, K Mine, D Kobayashi, M Inoue… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence.
T Kawashiri, K Mine, D Kobayashi, M Inoue… - … Journal of Molecular …, 2021 - europepmc.org
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
T Kawashiri, K Mine, D Kobayashi, M Inoue… - International Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: p> Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and
pancreatic cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor …
pancreatic cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor …
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
T Kawashiri, K Mine, D Kobayashi, M Inoue, S Ushio… - 2021 - agris.fao.org
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
[HTML][HTML] Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
T Kawashiri, K Mine, D Kobayashi, M Inoue… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
Therapeutic agents for oxaliplatin-induced peripheral neuropathy; experimental and clinical evidence
T Kawashiri, K Mine, D Kobayashi… - International …, 2021 - okayama.elsevierpure.com
抄録 Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and
pancreatic cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor …
pancreatic cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor …
[引用][C] Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
T Kawashiri, K Mine, D Kobayashi, M Inoue… - … Journal of Molecular …, 2021 - jglobal.jst.go.jp
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and
Clinical Evidence | Article Information | J-GLOBAL Art J-GLOBAL ID:202102286737521470 …
Clinical Evidence | Article Information | J-GLOBAL Art J-GLOBAL ID:202102286737521470 …
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
T Kawashiri, K Mine, D Kobayashi… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …